Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies

作者
Rabih Said,Apostolia M. Tsimberidou
出处
期刊:Expert Opinion on Drug Metabolism & Toxicology [Taylor & Francis]
卷期号:10 (3): 483-494 被引量:50
标识
DOI:10.1517/17425255.2014.885016
摘要

INTRODUCTION: Vincristine is a key agent for the treatment of acute lymphoblastic leukemia (ALL) and other lymphoid malignancies. The strong antineoplastic activity of vincristine has been limited by its pharmacological characteristics. AREAS COVERED: This paper reviews the role of vincristine in the treatment of lymphoid malignancies. This review summarizes its efficacy and toxicity, and focuses on the pharmacokinetic features of vincristine that affect clinical outcomes. EXPERT OPINION: As a single agent, vincristine is associated with brief and incomplete responses, but in combination with other agents, vincristine has dramatically improved the outcomes of lymphoid malignancies such as ALL. Vincristine is a key drug of hyper-fractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone, an intensive chemotherapeutic regimen for the treatment of ALL, and of cyclophosphamid, adriamycin, vincristine and prednisone, which has been used extensively in the treatment of patients with aggressive or indolent lymphomas and Richter syndrome. The strong antileukemic activity of vincristine has been limited by its variable and unpredictable pharmacological characteristics, narrow therapeutic index and neurotoxicity profile. These characteristics prompted the development of liposomal vincristine, which has optimized its clinical application. Liposomal vincristine has promising antileukemic activity, and it is approved by the FDA as a single agent for the treatment of relapsed/refractory Philadelphia chromosome-negative ALL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭的应助被情木花肆采纳,获得10
刚刚
刚刚
刚刚
奥特曼打小人完成签到,获得积分10
1秒前
Akim的应助被阿飞采纳,获得10
1秒前
1秒前
1秒前
Wenya完成签到,获得积分10
1秒前
123完成签到,获得积分10
2秒前
2秒前
2秒前
无语的太兰完成签到 ,获得积分10
2秒前
dxftx发布了新的文献求助10
3秒前
昭明完成签到,获得积分10
3秒前
3秒前
部长完成签到,获得积分10
3秒前
七十三度发布了新的文献求助10
4秒前
4秒前
4秒前
TYH完成签到,获得积分10
4秒前
Eternal完成签到,获得积分10
5秒前
爆米花的应助被zgw采纳,获得10
5秒前
小七完成签到,获得积分10
5秒前
431776592完成签到 ,获得积分10
5秒前
dd完成签到,获得积分20
5秒前
Wenya发布了新的文献求助10
5秒前
5秒前
玩命的友安完成签到,获得积分10
5秒前
6秒前
hhrr发布了新的文献求助10
6秒前
cc发布了新的文献求助10
6秒前
6秒前
汉堡包的应助被啊啊啊啊轩采纳,获得10
6秒前
dzh完成签到,获得积分10
7秒前
淡淡熠彤完成签到,获得积分10
7秒前
pinger完成签到,获得积分10
7秒前
journey完成签到,获得积分10
7秒前
李健的小迷弟的应助被Araung采纳,获得10
8秒前
Free完成签到,获得积分10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185